Beeline Medicines
Beeline Medicines is a clinical-stage biotech developing precision therapies for autoimmune and inflammatory diseases. It raised $426M in a Series A round in June 2026, one of the largest early-stage biotech financings of its time, and employs 54 people.
The growth story
Beeline Medicines grew from 1 to 54 employees between 2025 and 2026, raising $426M along the way, most recently a Series A in June 2026.
About
Beeline Medicines develops targeted therapies for autoimmune and inflammatory conditions, focusing on treatments that address the root causes of immune dysfunction. Its pipeline includes candidates based on validated biology and optimized molecular properties, aiming to create lasting patient impact.
The company raised $426M in its Series A round in 2026, backed by major investors like Bain Capital, Bristol-Myers Squibb, and CPP Investments. With 54 employees, it operates from Stamford, Connecticut, and has built a team with expertise from leading biotech firms.
Founders and leadership
Beeline Medicines' largest function is Operations, with 8 employees. The company has a lean structure, with a median tenure of just 1 year, suggesting rapid scaling since its founding in 2025.
The Beeline Medicines org chart
Saqib Islam (Chief Executive Officer) leads 45 mapped leaders with 5 direct reports. Click +N to expand a team; names link to the person’s public profile.
Talent flow
Beeline's team draws heavily from SpringWorks Therapeutics (16 hires) and Biogen (12 hires), with additional talent from Pfizer, Novartis, and Alexion Pharmaceuticals. Employees come from top schools like Stanford University and the University of Pennsylvania.
Most common previous employers of Beeline Medicines staff: SpringWorks Therapeutics (16), Biogen (12), Pfizer (6), Novartis (4), Alexion Pharmaceuticals (4), Apellis Pharmaceuticals (3).
Hiring now
What this company is made of
Most common skills at Beeline Medicines: Pharmaceutics (28), Biotechnology (24), Drug Development (19), Oncology (16), Life Sciences (14), Clinical Trials (14), Cross-functional Team Leadership (14), Clinical Development (13).
Where the team actually sits
Beeline Medicines people are concentrated in Greater Boston (11), Massachusetts, United States (9), New York, United States (6), New York City Metropolitan Area (4).
Search footprint
Beeline Medicines attracts about 30 organic search visits a month, traffic worth roughly $0K a month if bought through ads. It gained 1 ranking keywords and lost 1 in the last period.
Frequently asked
Beeline Medicines has 54 employees as of September 2026.
Beeline Medicines has raised $426M in total, most recently a Series A round in June 2026.
Saqib Islam (Chief Executive Officer) sits at the top of Beeline Medicines's reporting structure, with 5 direct reports.
The most common previous employers of current Beeline Medicines staff are SpringWorks Therapeutics (16 people), Biogen (12 people), Pfizer (6 people).
Beeline Medicines attracts about 30 organic search visits a month, worth roughly $0K a month in equivalent ad spend.
The most common skills among Beeline Medicines staff are Pharmaceutics, Biotechnology, Drug Development, Oncology, Life Sciences.
Beeline Medicines staff are concentrated in Greater Boston (11), Massachusetts, United States (9), New York, United States (6).
Beeline Medicines has about 10 people in Business Development, up 900% over the past year, as of September 2026.
Beeline Medicines has about 3 people in Healthcare Services, up 200% over the past year, as of September 2026.
Computed from 47 current and 1 former Beeline Medicines profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.